Cleerly names COO, CTO

Picture of Cleerly Cleerly : April 6, 2022

The hires come in the wake of completing a $43 million series B round of funding this summer.

Featured on Medical Marketing and Media by MM+M Staff

Cleerly, a company attempting to create a higher standard of care for heart disease, has tapped Brandon Atkinson as COO and Nick Nieslanik as CTO. The hires come weeks after Cleerly closed a $43 million series B round of funding this summer. Atkinson previously served as CEO of 46 Summits Consulting, while Nieslanik was formerly VP of engineering at Teladoc Health.


Read the full article HERE.
Cardiovascular Blind Spots and How Cleerly Is Changing the Game

Cardiovascular Blind Spots and How Cleerly Is Changing the Game

July 9, 2024

In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...

Read More
AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

February 15, 2024

Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...

Read More
Digital Health 50: The Most Promising Digital Health Companies of 2023

Digital Health 50: The Most Promising Digital Health Companies of 2023

December 27, 2023

Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...

Read More
CNBC Highlights Cleerly's Mission to Outsmart America's No. 1 Killer

CNBC Highlights Cleerly's Mission to Outsmart America's No. 1 Killer

Picture of Cleerly Cleerly : October 11, 2023

CNBC interviews Cleerly CEO, James Min, MD, on how Cleerly aims to improve personalized cardiac care and create a world without heart attacks. Read...

heart attack prevention heart disease technology
Read More

How to reduce heart attack rates

Picture of Cleerly Cleerly : April 6, 2022

To reduce heart attack rates, make CCTA the new standard of care.

Read More
MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk

MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk

Picture of Cleerly Cleerly : June 20, 2022

In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....

new standard of care CCTA-based approach heart attack prevention precision heart care
Read More